|
Volumn 11, Issue SUPPL. 3, 2000, Pages 141-144
|
Ovarial cancer: Best timing and applications of debulking surgery
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
CYCLOPHOSPHAMIDE;
PACLITAXEL;
CANCER ADJUVANT THERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GROWTH;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONFERENCE PAPER;
FEMALE;
GYNECOLOGIC CANCER;
HUMAN;
MAJOR CLINICAL STUDY;
METASTASIS;
MULTICENTER STUDY;
OVARY CANCER;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
QUALITY OF LIFE;
TREATMENT OUTCOME;
|
EID: 0033778497
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1093/annonc/11.suppl_3.141 Document Type: Conference Paper |
Times cited : (12)
|
References (18)
|